Lactoperoxidase (LPO), also known as salivary peroxidase (SPO) is an oxidoreductase encoded by the gene mapped to human chromosome 17q22. LPO is secreted from the mammary gland and salivary gland and is present in mature human milk. The encoded protein is a member of mammalian heme peroxidase superfamily.
Synonyms: Anti-FLJ23516; Anti-GRAIL; Anti-H2A/m; Anti-H2AFM; Anti-SPO; Anti-lactoperoxidase
MDL Number: MFCD01864823
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: Lactoperoxidase (LPO) catalyzes most of the peroxidase activity in mature milk. It plays a crucial role in protecting the lactating mammary gland and the intestinal tract of the neonate from microbial Infection. LPO is also contributes to the oxidation of various substrates, such as thiocyanate. This enzyme also delivers defense against toxic oxygen by detoxifying hydrogen peroxide in the presence of thiocyanate by converting it into hypothiocyanite, dioxygen and water.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC